UPDATE: Piper Sandler Starts Humacyte (HUMA) at Overweight
Tweet Send to a Friend
(Updated - September 16, 2021 9:06 AM EDT)
Piper Sandler analyst Matt O\'Brien initiates coverage on Humacyte (NASDAQ: HUMA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Matt O\'Brien initiates coverage on Humacyte (NASDAQ: HUMA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
